Access cutting-edge diabetic retinopathy treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access diabetic retinopathy specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetic retinopathy treatment provided free
This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study. The purpose of this study is to find out whether a medicine called BI 764524 helps people with diabetic retinopathy. The study also aims to find a suitable treatment plan for BI 764524. Participants are put into 5 groups by chance. Participants in groups 1, 2, and 3 get BI 764524. Over 1 year, they get a different number of injections of
Sponsor: Boehringer Ingelheim
Check if you qualify for this diabetic retinopathy clinical trial in Palo Alto, CA
If you're searching for diabetic retinopathy treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic retinopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.